Pharmacokinetics of eribulin mesylate in patients with solid tumours receiving repeated oral rifampicin.
Devriese LA, Witteveen PE, Wanders J, Law K, Edwards G, Reyderman L, Copalu W, Peng F, Marchetti S, Beijnen JH, Huitema AD, Voest EE, Schellens JH.
Devriese LA, et al. Among authors: wanders j.
Br J Clin Pharmacol. 2013 Feb;75(2):507-15. doi: 10.1111/j.1365-2125.2012.04381.x.
Br J Clin Pharmacol. 2013.
PMID: 22803519
Free PMC article.